Last filing: Aug 17, 2026. Most recent sale before this period: Feb 24, 2022.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Feb 24, 2022.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Accenture (ACN) | Director | Jul 19, 2016 | Aug 17, 2026 |
| Mondelez International (MDLZ) | Director | May 22, 2025 | May 21, 2026 |
| Abbott Laboratories (ABT) | Director | Dec 16, 2011 | Apr 28, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 14, 2026, Accenture: 12 shares granted. 1 filing: 1
- May 20, 2026, Mondelez International: 3,525 shares awarded. 1 filing: 1
- May 15, 2026, Accenture: 12 shares granted. 1 filing: 1
- Apr 24, 2026, Abbott Laboratories: 2,286 shares granted. 1 filing: 1
- Feb 13, 2026, Accenture: 7 shares granted; 4 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.